Anti-arthritic effect of GN1, a novel synthetic analog of glucosamine, in the collagen-induced arthritis model in rats
- 27 August 2011
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 60 (12) , 1113-1120
Abstract
Objective Glucosamine is a naturally occurring amino monosaccharide that maintains the elasticity and strength of the cartilage tissues. It has been used to treat osteoarthritis in humans; however, in severe conditions of inflammation and pain, glucosamine alone is not enough, and it is important to improve its biological activity. Our research group has recently taken an interest in the synthetic manipulation of amino sugars to develop some efficient pharmacophores, e.g., β-d-glucosamine, to combat rheumatoid arthritis, and tested its anti-arthritic effects in the collagen-induced arthritis (CIA) model in rats. Methods Arthritis was induced in female Sprague–Dawley rats by multiple intradermal injections of bovine type II collagen and challenged again with the same antigen preparation 7 days later. Arthritis was evaluated by arthritic score, body weight loss, paw volume measurement, and histological changes. Results The animals in the arthritic control group showed a gradual decrease in their body weight and concurrent increase in the paw volumes compared to the normal control group. In contrast, increased hind paw swelling was significantly suppressed with no further noticeable reduction in body weight in the glucosamine (p < 0.05) and GN1-treated (p < 0.02) arthritic animals. Histopathological evaluation of isolated knee joints by grading system and classification of the stages in arthritic lesion development revealed suppression of the inflammatory changes in the GN1-treated animals. Moreover, both the pro-inflammatory markers C-reactive protein (CRP) and low-density lipoprotein (LDL) levels were found to be significantly decreased in animals treated with GN1 (p < 0.03 for CRP and p < 0.05 for LDL) compared to the arthritic control group. Conclusion These results suggest that GN1 has both anti-arthritic and anti-inflammatory properties. Its effects in the CIA model suggest that it could be useful in the treatment of rheumatoid arthritis.Keywords
This publication has 69 references indexed in Scilit:
- Lipid profile in Tunisian patients with rheumatoid arthritisClinical Rheumatology, 2011
- Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid DiseasesPLOS ONE, 2010
- Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr−/−, ApoA-I−/− MiceJournal of Biological Chemistry, 2010
- Hyaluronan inhibits p38 mitogen-activated protein kinase via the receptors in rheumatoid arthritis chondrocytes stimulated with fibronectin fragmentClinical Rheumatology, 2010
- Modulation of multiple experimental arthritis models by collagen‐induced arthritis quantitative trait loci isolated in congenic rat lines: Different effects of non–major histocompatibility complex quantitative trait loci in males and femalesArthritis & Rheumatism, 2002
- Glucosamine Inhibits Inducible Nitric Oxide SynthesisBiochemical and Biophysical Research Communications, 2000
- Current Pharmacological Treatment of OsteoarthritisDrugs, 1996
- Effect of clodronate on established collagen-induced arthritis in ratsInflammation Research, 1995
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983